Article Information
History
- February 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Almahamoudou Mahamar, PhD1,*,
- Leen N Vanheer, MD2,#,*,
- Merel J Smit, MD3,
- Koualy Sanogo, MD1,
- Youssouf Sinaba, MD1,
- Sidi M. Niambele, PharmD1,
- Makonon Diallo, MD1,
- Oumar M Dicko, MD1,
- Richard S. Diarra, MD1,
- Seydina O Maguiraga, MD1,
- Ahamadou Youssouf, PharmD1,
- Adama Sacko, MS1,
- Sekouba Keita, MS1,
- Siaka Samake, Pharm D1,
- Adama Dembele, MS1,
- Karina Teelen3,
- Yahia Dicko, MD1,
- Sekou F. Traore, PhD1,
- Arjen Dondorp, MD4,5,
- Chris Drakeley, PhD2,†,
- William Stone, PhD2,† and
- Alassane Dicko, MD1,†
- 1Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali
- 2Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK, WC1E7HT
- 3Department of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
- 4Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
- 5Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
- ↵#Corresponding author:
Leen Vanheer: leen.vanheer{at}lshtm.ac.uk
Posted February 24, 2024.
Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised clinical trial
